Wednesday 24 October 2018

Flat Glass Coatings Market Expected To Trigger A Revenue Increase To USD 4.48 Billion By 2025:Key Participant Ferro Corporation


San Francisco, 25 October 2018 , The global flat glass coatings market size is expected to reach USD 4.48 billion by 2025, according to a new study by Grand View Research, Inc. It is anticipated to register a 20.2% CAGR over the forecast period. Massive demand for mirror and glass facades from commercial and residential sectors coupled with adoption from automotive and transportation sector is likely to drive demand over the forecast period.
Rising adoption of solar installations along with demand for environment-friendly renewable sources of energy are anticipated to drive demand for solar panels, augmenting flat glass coatings market. Moreover, rising awareness for energy conservation, self-sufficiency, and favorable government regulations are anticipated to further drive demand from architectural applications over the years to come. Countries such as Italy, U.K., U.S., Japan, China, India, and Germany featuring unilateral legislations to the Kyoto Protocol, aimed at reducing the greenhouse gas (GHG) emissions is also anticipated to promote market growth.
Water-based technology is anticipated to maintain its dominance in terms of market share over the forecast period. Wide usage owing to its high strength and premium quality is anticipated to be the primary driving factor for this segment. Overall performance of coating primarily depends on utilization of raw materials such as pigments, resins, and additives. However, nano-based technology is expected to ascend at a promising rate in near future on account of growing preferences for advanced materials in the manufacturing industry.
Growing need for utilization of sustainable energy, reduction in carbon footprint, and favorable government policies targeted at reducing consumption of fossil fuel are likely to propel growth of the solar power sector. Solar module industry is anticipated to register major demand for flat glass coatings in solar projects.
Full Research Report On Flat Glass Coatings Market Analysis:
www.grandviewresearch.com/industry-analysis/flat-glass-coatings-market


Further key findings from the repot suggest:
·         Asia Pacific was the dominant regional segment and is expected to register the fastest volume-based CAGR of 19.9% over the forecast period. Rising infrastructural investments and favorable regulations are the major regional market drivers
·         China was the leading player on account of its burgeoning automobile industry, coupled with massive infrastructural investments targeted to meet needs from residential sector
·         Epoxy resins held a considerable revenue share on account of its unique properties such as mechanical strength, high thermal stability, electrical and heat resistance, adhesion, and mechanical resistance
·         Key participants in the global flat glass coatings market include Arkema Inc.; Fenzi Spa; Ferro Corporation; Hesse Gmbh & Co. Kg; The Sherwin-Williams Company; and Vitro, S.A.B. de C.V
·         In October 2016, Vitro, S.A.B. de C.V decided to expand its coating production capability along with the construction of MSVD glass coater. These coaters are utilized to produce low emissive, and performance and energy efficient glass.
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/bulk-chemicals
Grand View Research has segmented the global flat glass coatings market on the basis of resin, technology, application, and region:
Flat Glass Coatings Resin Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Polyurethane
·         Acrylic
·         Epoxy
·         Others
Flat Glass Coatings Technology Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Solvent-based
·         Water-based
·         Nano-based
Flat Glass Coatings Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         Solar Power
·         Mirror
·         Architectural
·         Automotive & Transportation
·         Other
Flat Glass Coatings Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
o    Mexico
·         Europe
o    Germany
o    France
o    U.K.
o    Turkey
o    Italy
o    Netherlands
o    Belgium
o    Spain
·         Asia Pacific
o    China
o    India
o    Japan
o    Malaysia
o    Taiwan
o    South Korea
o    Vietnam
·         Central & South America
o    Brazil
o    Chile
·         Middle East & Africa
o    Saudi Arabia
o    South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-flat-glass-coatings-market


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


at No comments:
Labels: , , , , , ,

Therapeutic Drug Monitoring Market Expected To Trigger A Revenue Increase To USD 3.37 Billion By 2024:Key Participant Siemens Healthcare GmbH


San Francisco, 24 October 2018 , The global therapeutic drug monitoring market is expected to reach over USD 3.37 billion by 2024, according to a new report by Grand View Research, Inc. Recent technological advancements in the Point-of-Care (PoC) devices hold considerable transformative promises for the personalized predictive and preventive medicine. Therapeutic Drug Monitoring (TDM) forms a foundational part to the devising of personalized treatment plans for patients; and the advent of PoC diagnostic devices that yield quantitative measurements of the drug concentration plays a pivotal role in supporting the development of the precision medicine field in the healthcare sector. However, the broad application of the PoC devices for patient monitoring is still lagging behind. The presence of this untapped opportunity is one of the high impact rendering drivers for the market growth.
The employment of continuous therapeutic drug and metabolite monitoring in the early phase of the medication regimen, administered post-organ transplantation, forms a major application in the areas of critical care medicine and organ transplantation, which is expected to propel the growth of the therapeutic drug monitoring market over the forecast period. In addition, the imposing burden of diseases, such as epilepsy and cancer, the rising government initiatives, and the presence of high-unmet needs are some of the crucial determinants expected to further favor the emergence of this market.
Full Research Report On Therapeutic Drug Monitoring Market Analysis:
www.grandviewresearch.com/industry-analysis/therapeutic-drug-monitoring-market

Further key findings from the study suggest:
·         The consumables segment covered over 65% of the market share in 2015 as a consequence of the extensive requirement of the consumables in the research laboratories and due to the repeat purchase of the kits and reagents.
·         The immunoassay segment held the largest market share in 2015. The presence of several commercially available immunoassays combined with their associated benefits including the cost effectiveness and easy-to-handle nature of the products are the key drivers for the growth of this segment.
·         The proteomics category is expected to be the fastest growing technology segment due to the advent of various proteomic technologies, such as isotope-coded affinity tags, next generation sequencing, and protein microarray platforms that enable rapid mining of the proteome.
·         The hospital is the largest end-use segment with a share of over 60% in 2015. In larger hospitals, various underlying technologies are employed to perform immunoassays; these comprise chemiluminescence, nephelometry, colorimetry, and fluorescence, which are available for the testing of a wide ranging drug panel.
·         The drug monitoring for the immunosuppressants is one of the fastest growing application segments owing to the introduction of novel TDM point-of-care testing devices for the evaluation of the concentration of administered immunosuppressants and the complementary metabolites, in order to achieve a prominent therapeutic effect while preventing drug toxicity events in patients that have undergone transplantations.
·         In 2015, North America was the highest revenue generating region with revenue generated over USD 900 million. The rising number of R&D activities coupled with the high awareness about personalized therapy is the major determining factor for the large share captured by the North America region.
·         Few of the leading market players are Roche Diagnostics, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Abbott Laboratories, Inc., Agilent Technologies, Inc., bioMérieux, Inc., and Alere, Inc. The persistent R&D efforts are being undertaken along with numerous other strategic endeavors being adopted by the market players with the objective of enhancing the present drug monitoring practices and to develop novel technologies.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the therapeutic drug monitoring market on the basis of product, technology, application, end-use, and region:
Therapeutic Drug Monitoring Market, Product Outlook, by Revenue (USD Million, 2013 - 2024)
·         Consumables
·         Equipment
·         Others
Therapeutic Drug Monitoring Market, Technology Outlook, by Revenue (USD Million, 2013 - 2024)
·         Immunoassays
·         Proteomic technologies
·         Others
Therapeutic Drug Monitoring Market Drug, Class Outlook, by Revenue (USD Million, 2013 - 2024)
·         Anti-epileptics
·         Antibiotics
·         Immunosuppressants
·         Psychoactive drugs
·         Antiarrhythmic drugs
·         Others
Therapeutic Drug Monitoring Market, End-use Outlook, by Revenue (USD Million, 2013 - 2024)
·         Hospital labs
·         Private labs
·         Others
Therapeutic Drug Monitoring Market, Regional Outlook, by Revenue (USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
·         MEA
o    South Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


at No comments:
Labels: , , , ,

Personal Emergency Response Systems Market Expected To Trigger A Revenue Increase To USD 11.1 Billion By 2025:Key Participant Koninklijke Philips N.V., ADT Security Services


San Francisco, 24 October 2018 , The global PERS market is estimated to reach USD 11.1 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of Alzheimer’s disease and rising life expectancy are estimated to boost the market for Medical alert systems. Moreover, increasing number of mergers and acquisitions by market players are also expected to accelerate growth.
Furthermore, the elderly is more prone to falls, and according to a study, 50% of seniors aged 80 years and 30% of seniors aged 65 fall every year. In addition, those suffering from diseases such as epilepsy, Alzheimer’s, Parkinson’s, multiple sclerosis, and muscular dystrophy, are at a higher risk of falling. These are major factors that are estimated to drive the market.
In addition, availability of technologically advanced medical alert systems, such as those enabled with W-Fi, GPS, BLE, and radio frequency, help caregivers in finding wandering elders. Combination of PERS with mobile communication technology has enabled not only monitoring of users when they are at home, but also when they are traveling and leading active lives. Devices are now capable of predictive or automatic fall detection and connect the elderly to their caregivers and medical professionals. Increasing awareness about Internet of Things has presented a huge opportunity for medical alert systems to create connected homes. Thus, technologically advanced PERS devices have accelerated the growth of the market.

Further Key Findings From the Report Suggest:
·         Standalone devices are expected to be one of the fastest growing segments over the forecast period owing to their accessibility and affordability
·         Mobile systems were the largest segment in 2016 due to their widespread utilization
·         Home-based users segment is estimated to be the fastest growing end-use segment over the forecast period and it was the largest end-use segment in 2016
·         North America dominated the market in 2016 owing to local presence of key players and increasing number of mergers and acquisitions
·         Asia Pacific is expected to be the fastest growing region over the next decade with a lucrative CAGR from 2017 to 2025 due to improved economic conditions and rise in healthcare expenditure
·         Some of the key players are Koninklijke Philips N.V.; ADT Security Services; Bay Alarm Medical; VRI, Inc.; Life Alert Emergency Response, Inc.; Tunstall; Medical Guardian LLC; AlertOne Services LLC; GreatCall; Rescue Alert; LogicMark; and Nortek Security and Control
·         Most of the key players are focusing on expanding their product portfolios, and engaging in collaborations and acquisitions
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the global personal emergency response systems market on the basis of type, end-use, and region:
Type Outlook (Revenue, USD billion, 2014 - 2025)
·         Landline PERS
·         Mobile PERS
·         Standalone PERS
End-use Outlook (Revenue, USD billion, 2014 - 2025)
·         Home-based Users
·         Nursing Homes
·         Assisted Living Facilities
·         Hospices
Regional Outlook (Revenue, USD billion, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


at No comments:
Labels: , ,

Bioinformatics Market Expected To Trigger A Revenue Increase To USD 13.47 Billion By 2020:Key Participant Life Technologies Corporation, Agilent technologies


San Francisco, 24 October 2018 ,  The global bioinformatics market is expected to reach USD 13.47 billion by 2020 growing at an estimated CAGR of 21.2% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing clinical development of biopharmaceutical and increasing need for three dimensional drug designing technology are expected to drive the market growth over the next five years.
Further development of bioinformatics tools, platforms and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market. Increasing demand for faster development of novel API and biopharmaceuticals is also expected to enhance the growth of this industry.
Full Research Report On Bioinformatics Market Analysis:www.grandviewresearch.com/industry-analysis/bioinformatics-industry

Growth in the number of research and development studies in various ‘-omics’ related segments and need for integration of the large amounts of biological data generated from these studies is also expected to encourage industry players to develop faster, more efficient and versatile bioinformatics software cum platforms for commercialization.
Bio-content processing accounted for over 47% of the revenue share in 2013. The presence of increasing market demand for genetic databases management, and need for related sequence, structural and phylogenic analysis tools and software is the primary factor accounting for this large share.
Moreover, the sequence and structural analysis platform segment is expected to grow at the fastest CAGR of over 20% over the forecast period owing to the development of next generation sequencing and expected reduction in cost of whole genome exome sequencing. These factors are expected to have a significantly positive impact on the overall growth of this market in the next five years.
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/healthcare-it
Chemo-informatics and genomics accounted for over 50% of revenue share in 2013. Growing demand for novel biomarkers for R&D of biosimilar drugs and biopharmaceuticals is expected to significantly enhance the market penetration over the forecast period.
Proteomic applications are expected to attract a considerable amount of R&D investment in the near future and witness a lucrative growth over the forecast period. Developments in three dimensional drug development technologies are further expected to boost the growth of this segment.
North America was observed to account for over 40% of the global revenue in 2013. Factors accounting for this large share include the presence of large pharmaceutical companies in the region, which are involved in the clinical development of novel APIs and biosimilar drugs. The presence of a technologically advanced healthcare R&D framework also enhances this region’s investment capabilities for the development of the aforementioned market segments.
Asia Pacific is expected to grow at the fastest CAGR over the forecast period owing to the presence of companies providing outsourcing services to the industry for larger eastern industry players. Furthermore, the presence of high unmet industry need is also expected to be significant reason to impact the growth of this region positively over the forecast period.
Key players in this industry include IBM Life Sciences, BIOVIA, Life Technologies Corporation, Agilent technologies, 3rdMillennium Inc., Celera Corporation, Affymetrix, BioWisdom Ltd., and Rosetta Biosoftware.


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)